Concepedia

Katharine K. Duncan

KK

Statistics

Publications

14

Citations

906

H-Index

14

Active since

2004

Affiliations

Scripps Research Institute(Current)

McLean Hospital

Harvard University

Temple University

The University of Kansas Cancer Center

Katharine K. Duncan is an author at Scripps Research Institute specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

2004–2017

14

Publications

14

Iron(III)/NaBH<sub>4</sub>-Mediated Additions to Unactivated Alkenes: Synthesis of Novel 20′-Vinblastine Analogues

Erick K. Leggans, Timothy J. Barker, Katharine K. Duncan et al. · Organic Letters · 2012 · 312 citations

, , +17

8-<i>epi</i>-Salvinorin B: crystal structure and affinity at the κ opioid receptor

Thomas A. Munro, Katharine K. Duncan, Richard J. Staples et al. · Beilstein Journal of Organic Chemistry · 2007 · 92 citations · Full text

, , +11

Standard protecting groups create potent and selective κ opioids: Salvinorin B alkoxymethyl ethers

Thomas A. Munro, Katharine K. Duncan, Wei Xu et al. · Bioorganic & Medicinal Chemistry · 2007 · 68 citations · Full text

, , +9

A Remarkable Series of Vinblastine Analogues Displaying Enhanced Activity and an Unprecedented Tubulin Binding Steric Tolerance: C20′ Urea Derivatives

Erick K. Leggans, Katharine K. Duncan, Timothy J. Barker et al. · Journal of Medicinal Chemistry · 2012 · 65 citations

, , +15

10′-Fluorovinblastine and 10′-Fluorovincristine: Synthesis of a Key Series of Modified Vinca Alkaloids

Hiroaki Gotoh, Katharine K. Duncan, W. M. Robertson et al. · ACS Medicinal Chemistry Letters · 2011 · 61 citations

, , +15

1–5 of 14